As Pradaxa Lawsuits Mount, Bernstein Liebhard LLP Comments on Report Naming Pradaxa the Country’s Most Complained About Medication

Share Article

The Firm is investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious episodes of internal bleeding, allegedly due to their use of the blood thinner.

Free Case Review
The complaints made to the FDA relating to Pradaxa echo what we have heard from our own clients, and are similar to the allegations put forth in thousands of Pradaxa lawsuits currently being litigated in U.S. courts.

As Pradaxa lawsuits ( ) continue to mount in federal court, Bernstein Liebhard LLP notes that a recent media investigation has found that the blood thinner ranks as the most complained about prescription medication in the U.S. According to 7 Action News in Detroit, data from the U.S. Food & Drug Administration (FDA) indicates that Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries. Complaints related to Pradaxa outpaced those for any other prescription drug between 2011 and 2012. Among other things, the report noted that Pradaxa was associated with a high risk of internal bleeding. *

“The complaints made to the FDA relating to Pradaxa echo what we have heard from our own clients, and are similar to the allegations put forth in thousands of Pradaxa lawsuits currently being litigated in U.S. courts,” says Bernstein Liebhard LLP, nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free legal evaluations to individuals who suffered cerebral hemorrhage, gastrointestinal bleeding, and other serious episodes of internal bleeding, allegedly due to Pradaxa.

Pradaxa Bleeding Allegations
According to a recent report from Reuters, Pradaxa was the first among a new class of blood thinners intended to replace warfarin (sold under the brand name Coumadin) to prevent strokes in people with atrial fibrillation. However, there currently exists no readily available antidote to reverse Pradaxa’s blood thinning effects in patients who experience internal bleeding while using the medication. Warfarin bleeding, by contrast, can be stopped easily via the administration of vitamin K.**

In December 2013, the FDA announced a new, large-scale assessment of Pradaxa bleeding rates in relation to warfarin.

According to court documents, more than 2,300 Pradaxa lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois on behalf of individuals who were allegedly injured by Pradaxa. Among other things, the lawsuits accuse Boehringer Ingelheim of failing to provide patients with adequate warnings regarding the risk for internal hemorrhaging, especially the lack of an antidote to reverse Pradaxa bleeding. The first bellwether trial of a federal Pradaxa lawsuit is scheduled to begin in September.

Individuals who allegedly suffered serious internal bleeding due to Pradaxa may be entitled to compensation for medical bills, lost wages, pain and suffering and more. For more information on filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.

*, 7 Action News, February 25, 2014
**, Reuters, February 13, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website